← Back

Huaxia Eye Hospital Group Co. Ltd. A

Huaxia Eye Hospital Group Co., Ltd. operates an ophthalmic medical chain in China and internationally. It provides general ophthalmology diagnosis and treatment, along with other ophthalmic medical services for patients with eye disease and myopia, as well as prevention and intervention work for the public. Its services cover cataract, refractive errors, fundus, strabismus and amblyopia, pediatric ophthalmology, ocular surface, glaucoma, orbital and ocular tumors, optometry, and ocular trauma, and it also engages in community services. The company was founded in 1997 and is based in Xiamen, China.

Country
Price · split & dividend adjusted
News & notes moving 301267.CS
301267.CS

Hangxiao Steel Structure Secures $166 Million Major Order

Hangxiao Steel Structure has signed a $166 million procurement contract for a DEP project with Dangote Petroleum Refining Free Zone Enterprise, securing a major order. Meanwhile, three government departments issued guidelines on overseas competition conduct and compliance building for the automotive industry, regulating companies' overseas pricing strategies. The world's first international standard for legged robots, led by China, has been officially released, and China has achieved a major breakthrough in the comprehensive utilization of refractory iron ore resources. China Securities Index Company will launch four artificial intelligence-related indices. Eurozone inflation rose to 3.3% in August. Other company updates include: Huanrui Century said revenue from AIGC business accounts for a low proportion; Bona Film Group's AI film and television business is still in its early stages; Seagull Housing reminded of the risk of abnormal share price increases; Jitai Corporation's liquid cooling silicone oil has not formed large-scale orders; BAIC BluePark's August sales rose 29.88% year-on-year; Huaxia Eye Hospital's actual controller plans to increase holdings by no less than 30 million yuan; Northeast Pharmaceutical's director plans to reduce holdings; KTK Group's shareholder plans to reduce holdings by no more than 3%; Zhongji Innolight repurchased 374,100 shares for the first time at a cost of 318 million yuan; Shandong University Electric Power won a bid for a China Southern Power Grid project worth about 15.806 million yuan; Far East Smarter Energy's August winning bids and signed contract orders totaled 1.78 billion yuan; Sunshine Corporation's subsidiary signed a 633 million yuan server leasing contract; and GigaDevice expects the DRAM supply shortage will not ease significantly by 2027.
数据宝·17dRead more →
301267.CS3

Huaxia Eye Hospital's 2026 interim report shows net profit of 292 million yuan

Huaxia Eye Hospital released its 2026 interim report. During the reporting period, the company's total operating revenue was 2.185 billion yuan, net profit attributable to the parent company was 292 million yuan, and net cash inflow from operating activities was 481 million yuan. The company's latest asset-liability ratio was 28.07 percent, up 1.00 percentage point from the previous quarter and up 2.29 percentage points from the same period last year. Gross margin was 44.12 percent, down 2.02 percentage points from the previous quarter and down 1.08 percentage points from the same period last year. Return on equity was 5.39 percent, and diluted earnings per share was 0.35 yuan. The company had 20,100 shareholders, and the top ten shareholders held 690 million shares, accounting for 82.10 percent of total share capital.
Jiemian·22dRead more →
301267.CS

Huaxia Eye Hospital Shareholder Plans to Reduce Stake by Up to 1.4856%

Huaxia Eye Hospital announced on August 27 that shareholder Xiamen Hanwei Equity Investment Partnership plans to reduce its holdings by no more than 12.3673 million shares through block trading and centralized bidding, representing 1.4856% of the company's total share capital excluding repurchased shares.
每日经济新闻·23dRead more →